Neurology

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductionsReporting segment formerly known as…

4 months ago

Global Contract Manufacturing Market on Track for $968.7 Billion by 2030

"With rising demand across pharma, electronics, and automotive sectors, contract manufacturing offers cost savings, supply chain stability, and access to…

4 months ago

The Dawn of Medical Superintelligence: ATLAS AI

In a Breakthrough Study ATLAS AI Outperforms Clinicians and ChatGPT in Medical Diagnoses While Slashing Unnecessary Tests LOS ANGLES, Aug.…

4 months ago

CRC Becomes Accredited Medidata Rave® EDC Partner

ST. PETERSBURG, Fla., Aug. 12, 2025 /PRNewswire/ -- Cognitive Research Corporation (CRC), a full-service CRO specializing in neuroscience, has officially…

4 months ago

SamaCare Ranks No. 578 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies

This Marks SamaCare's Second Time on the List, Ranking in the top 12% of America's Fastest-Growing Companies SAN FRANCISCO, Aug. 12,…

4 months ago

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology…

4 months ago

Biogen and Stoke Therapeutics Announce First Patient Dosed in Phase 3 EMPEROR Study of Zorevunersen, a Potential Disease-Modifying Treatment for Dravet Syndrome

– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment…

4 months ago

ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 Guidance

Generated record quarterly net revenues of $211.4 million, representing year-over-year growth of 53.1% on a reported basis and 37.0% on…

4 months ago

Nxera Pharma Operational Highlights and Consolidated Results for the Second Quarter and First Half 2025

Tokyo, Japan and Cambridge, UK, 8 August 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update…

4 months ago

Creyos Expands Session Notes to Turn Cognitive Health Testing Into Timely Clinical Action

Developed by world-renowned neuroscientist Professor Adrian Owen, Creyos helps providers detect cognitive impairment through a scientifically validated brain health assessment platform…

4 months ago